• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶激活受体4在食管鳞状细胞癌中的表达降低。

The decreased expression of protease-activated receptor 4 in esophageal squamous carcinoma.

作者信息

Lee S, Jiang P, Wang W, Feng W, Yu G

出版信息

Neoplasma. 2014;61(5):546-52. doi: 10.4149/neo_2014_067.

DOI:10.4149/neo_2014_067
PMID:25030438
Abstract

Protease-activated receptors (PARs) are a unique family of G-protein coupled receptors. PAR4, a member of PARs family, was reported to be related to the development of cancers. Whether PAR4 plays a role in the progress of esophageal squamous cancer is unknown. In this study, differential expression of PAR4 in esophageal squamous cancer was measured by real-time PCR (n = 28), western blot and tissue microarrays (n = 78). The results showed that PAR4 expression was remarkably decreased in esophageal squamous cancer tissues compared with the matched noncancerous tissues, especially in low differentiation and positive distant metastasis carcinoma tissues. Furthermore, the methylation level of PAR4 promoter in esophageal cancer cells and normal epithelial cells was determined. Human esophageal cancer cells TE-1 displayed significant hypermethylation of 19 CpG sites, but pronounced hypomethylation of the sites in esophageal epithelial cells HEEpiC. The results suggested that down-regulation expression of PAR4 occurs frequently in esophageal squamous cancers, and the loss of PAR4 expression may partly result from hypermethylation of the PAR4 promoter. That PAR4 expression difference in tumor progression possibly makes PAR4 become a molecular mark of tumor diagnosis.

摘要

蛋白酶激活受体(PARs)是一类独特的G蛋白偶联受体家族。PAR4是PARs家族的成员之一,据报道与癌症的发展有关。PAR4在食管鳞状癌进展中是否发挥作用尚不清楚。在本研究中,通过实时PCR(n = 28)、蛋白质印迹法和组织芯片(n = 78)检测了PAR4在食管鳞状癌中的差异表达。结果显示,与配对的非癌组织相比,食管鳞状癌组织中PAR4表达显著降低,尤其是在低分化和远处转移阳性的癌组织中。此外,还测定了食管癌细胞和正常上皮细胞中PAR4启动子的甲基化水平。人食管癌细胞TE-1显示19个CpG位点显著高甲基化,但食管上皮细胞HEEpiC中的这些位点则明显低甲基化。结果表明,PAR4表达下调在食管鳞状癌中频繁发生,PAR4表达缺失可能部分归因于PAR4启动子的高甲基化。PAR4在肿瘤进展中的表达差异可能使PAR4成为肿瘤诊断的分子标志物。

相似文献

1
The decreased expression of protease-activated receptor 4 in esophageal squamous carcinoma.蛋白酶激活受体4在食管鳞状细胞癌中的表达降低。
Neoplasma. 2014;61(5):546-52. doi: 10.4149/neo_2014_067.
2
Protease-activated receptor (PAR)1, PAR2 and PAR4 expressions in esophageal squamous cell carcinoma.蛋白酶激活受体(PAR)1、PAR2和PAR4在食管鳞状细胞癌中的表达。
Dongwuxue Yanjiu. 2014 Sep;35(5):420-5. doi: 10.13918/j.issn.2095-8137.2014.5.420.
3
Increased expression of protease-activated receptor 4 and Trefoil factor 2 in human colorectal cancer.蛋白酶激活受体 4 和三叶因子 2 在人结直肠癌中的表达增加。
PLoS One. 2015 Apr 13;10(4):e0122678. doi: 10.1371/journal.pone.0122678. eCollection 2015.
4
Decreased expression of protease-activated receptor 4 in human gastric cancer.蛋白酶激活受体 4 在人胃癌中的表达降低。
Int J Biochem Cell Biol. 2011 Sep;43(9):1277-83. doi: 10.1016/j.biocel.2011.05.008. Epub 2011 May 25.
5
Quantitative Proteomics Identify the Possible Tumor Suppressive Role of Protease-Activated Receptor-4 in Esophageal Squamous Cell Carcinoma Cells.定量蛋白质组学鉴定蛋白酶激活受体 4 在食管鳞癌细胞中可能的肿瘤抑制作用。
Pathol Oncol Res. 2019 Jul;25(3):937-943. doi: 10.1007/s12253-018-0395-7. Epub 2018 Mar 4.
6
Activation of PAR4 Upregulates p16 through Inhibition of DNMT1 and HDAC2 Expression via MAPK Signals in Esophageal Squamous Cell Carcinoma Cells.PAR4 激活通过 MAPK 信号抑制 DNMT1 和 HDAC2 表达而上调 p16 在食管鳞癌细胞中的作用。
J Immunol Res. 2018 Sep 30;2018:4735752. doi: 10.1155/2018/4735752. eCollection 2018.
7
Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.甲基化介导的潜在抑癌基因miR-203a和miR-203b的抑制作用促进了食管鳞状细胞癌的发展。
Tumour Biol. 2016 Apr;37(4):5621-32. doi: 10.1007/s13277-015-4432-9. Epub 2015 Nov 17.
8
Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.人食管鳞状细胞癌中人白细胞抗原 I 启动子的甲基化及其组织病理学特征。
J Thorac Cardiovasc Surg. 2011 Mar;141(3):808-14. doi: 10.1016/j.jtcvs.2010.04.031.
9
Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma.异常甲基化介导的长链非编码RNA LOC100130476下调与食管鳞状细胞癌的恶性进展相关。
Dig Liver Dis. 2016 Aug;48(8):961-9. doi: 10.1016/j.dld.2016.05.010. Epub 2016 Jun 1.
10
Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.异常甲基化导致长链非编码 RNA CTC-276P9.1 沉默与食管鳞状细胞癌的恶性进展相关。
Clin Exp Metastasis. 2018 Feb;35(1-2):53-68. doi: 10.1007/s10585-018-9881-2. Epub 2018 Mar 10.

引用本文的文献

1
PAR Serves an Indispensable Role in Controlling PAR Oncogenicity: The β-Catenin-p53 Axis.PAR在控制PAR致癌性中发挥不可或缺的作用:β-连环蛋白-p53轴
Int J Mol Sci. 2025 Mar 19;26(6):2780. doi: 10.3390/ijms26062780.
2
PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways.蛋白酶激活受体1(PAR1)和蛋白酶激活受体4(PAR4)通过信号转导和转录激活因子3(STAT3)及核因子κB(NF-κB)信号通路对食管鳞状细胞癌的肿瘤生长和转移发挥相反作用。
Cancer Cell Int. 2021 Nov 29;21(1):637. doi: 10.1186/s12935-021-02354-4.
3
Activation of PAR4 Upregulates p16 through Inhibition of DNMT1 and HDAC2 Expression via MAPK Signals in Esophageal Squamous Cell Carcinoma Cells.
PAR4 激活通过 MAPK 信号抑制 DNMT1 和 HDAC2 表达而上调 p16 在食管鳞癌细胞中的作用。
J Immunol Res. 2018 Sep 30;2018:4735752. doi: 10.1155/2018/4735752. eCollection 2018.
4
PAR4 overexpression promotes colorectal cancer cell proliferation and migration.PAR4过表达促进结肠癌细胞的增殖和迁移。
Oncol Lett. 2018 Nov;16(5):5745-5752. doi: 10.3892/ol.2018.9407. Epub 2018 Sep 5.
5
Quantitative Proteomics Identify the Possible Tumor Suppressive Role of Protease-Activated Receptor-4 in Esophageal Squamous Cell Carcinoma Cells.定量蛋白质组学鉴定蛋白酶激活受体 4 在食管鳞癌细胞中可能的肿瘤抑制作用。
Pathol Oncol Res. 2019 Jul;25(3):937-943. doi: 10.1007/s12253-018-0395-7. Epub 2018 Mar 4.
6
Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.食管鳞状细胞癌中的基因组和表观基因组畸变及其对患者的影响
Gastroenterology. 2018 Jan;154(2):374-389. doi: 10.1053/j.gastro.2017.06.066. Epub 2017 Jul 27.
7
Increased expression of protease-activated receptor 4 and Trefoil factor 2 in human colorectal cancer.蛋白酶激活受体 4 和三叶因子 2 在人结直肠癌中的表达增加。
PLoS One. 2015 Apr 13;10(4):e0122678. doi: 10.1371/journal.pone.0122678. eCollection 2015.